NMPA Approval

Carboprost Tromethamine Injection

Approval Number

国药准字HJ20170146

Company辉瑞

Registration Date

February 22, 2022

Previous Approval Numbers

H20170146

Drug Information

Generic Name

卡前列素氨丁三醇注射液

Trade Name

欣母沛

Dosage Form

注射剂

Strength

1ml:250μg

Drug Type

化学药品

Registration Date

February 22, 2022

Expiry Date

February 21, 2027

Company Name辉瑞

Company Address

235 East 42nd Street,New York,NY 10017 United States of America

Company Address

7000 Portage Road,Kalamazoo,MI 49001 United States of America

Empowering clinical research with data-driven insights and AI-powered tools.

卡前列素氨丁三醇注射液 - NMPA 批准文号 | MedPath